Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Sangri Today

Jun 1, 2022 - 16:42

0

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines

Sangri Today Sangri Today is a Weekly Bilingual Newspaper and website of news and current affairs that publishes news reports from various places, from general reports.

Related Posts

Pharmacy Management System Market Worth USD 15,491 Million by 2030 at 11.4% CAGR - Report by Market Research Future (MRFR)

Pharmacy Management System Market Worth USD 15,491 Mill...

Sangri Today May 24, 2022 0

Imaging Agents Market to hit USD 14.2 billion by 2030, Says Global Market Insights Inc.

Imaging Agents Market to hit USD 14.2 billion by 2030, ...

Sangri Today May 23, 2022 0

PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ at the Minimum Number of Patients Targeted Following Unblinded Interim Efficacy Analysis

PolyPid Announces Recommendation by Data Safety Monitor...

Sangri Today May 23, 2022 0

Vera Therapeutics Announces New Atacicept Phase 2 Clinical Data in Two Oral Presentations at the 59th European Renal Association Congress

Vera Therapeutics Announces New Atacicept Phase 2 Clini...

Sangri Today May 23, 2022 0

Softgel Capsule Market Size Worth USD 11,050 Million by 2030 at 5.3% CAGR - Report by Market Research Future (MRFR)

Softgel Capsule Market Size Worth USD 11,050 Million by...

Sangri Today May 23, 2022 0

Exavir Therapeutics Completes $4M Seed Financing from Key Investors

Exavir Therapeutics Completes $4M Seed Financing from K...

Sangri Today May 23, 2022 0